Intratympanic gentamicin therapy for intractable Ménière's disease

Acta Oto-Laryngologica

Volumn 127, Issue 6, 2007, Pages 605-612

  De Beer, Lieke ^a   Stokroos, Robert ^a   Kingma, Herman ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chemical labyrinthine ablation treatment; Hearing results outcome; Meniere's disease; Vertigo

Indexed keywords

GENTAMICIN;

ADULT; AGED; AREFLEXIA; ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEARING DISORDER; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MENIERE DISEASE; PRIORITY JOURNAL; REPEATED DRUG DOSE; RETROSPECTIVE STUDY; TREATMENT DURATION; VERTIGO;

ADULT; AGED; ANTI-BACTERIAL AGENTS; AUDIOMETRY, PURE-TONE; CALORIC TESTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENTAMICINS; HEARING LOSS, SENSORINEURAL; HUMANS; INJECTIONS; MALE; MENIERE'S DISEASE; MIDDLE AGED; REFLEX, ABNORMAL; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TYMPANIC MEMBRANE;

EID: 34248551383     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480600951475     Document Type: Article

References (18)

1. Schuknecht HF. Ablation therapy in the management of Méniè re's disease. Acta Otolaryngol Suppl 1957;132:1-42.
2. Bagger-Sjoback D, Bergenius J, Lunberg AM. Inner ear effects of topical gentamicin treatment in patients with Ménière's disease. Am J Otol 1990;11:406-10.
3. Perez N, Martin E, Garcia-Tapia R. Intratympanic gentamicin for intractable Ménière's disease. Laryngoscope 2003;113:456-64.
4. Bottril I, Wills AD, Mitchell AL. Intratympanic gentamicin for unilateral Ménière's disease: results of therapy. Clin Otolaryngol 2003;28:133-41.
5. Raanen CK, Vitaly K, Einarson TR, Kozer E, Koren G, Rutka JA. Intratympanic gentamicin for Ménière's disease: a meta-analysis. Laryngoscope 2004;114:2085-91.
6. Lange G, Maurer J, Mann W. Long-term results after interval therapy with intratympanic gentamicin for Ménière's disease. Laryngoscope 2004;114:102-5.
7. Kaasinen S, Pyykko I, Ishizaki H, Aalto H. Intratympanic gentamicin in Ménière's disease. Acta Otolaryngol (Stockh) 1998;118:294-8.
8. McFeely WJ, Singleton GT, Rodriguez FJ, Antonelli PJ. Intratympanic gentamicin treatment for Ménière's disease. Otolaryngol Head Neck Surg 1998;118:589-96.
9. Kaplan DM, Nedzelski JH, Chen JM, Shipp DB. Intratympanic gentamicin for the treatment of unilateral Ménière's disease. Laryngoscope 2000;110:1298-305.
10. Ching Wu I, Minor LB. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease. Laryngoscope 2003;113:815-20.
11. Eklund S, Pyykko I, Aalto H, Ishizaki H, Vasama JP. Effect of intratympanic gentamicin on hearing and tinnitus in Ménière's disease. Am J Otol 1999;20:350-6.
12. Youssef TF, Poe DS. Intratympanic gentamicin injection for the treatment of Ménière's disease. Am J Otol 1998;19:435-42.
13. Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis. Otol Neurotol 2004;25:544-52.
14. Soderman ACH, Bergenius J, Bagger-Sjoback D, Tjell C, Langius C. Patients subjective evaluations of quality of life related to disease-specific symptoms, sense of coherence, and treatment in Ménière's disease. Otol Neurotol 2001;22:526-33.
15. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière's disease. Otolaryngol Head Neck Surg 1995;113:181-5.
16. Stokroos R, Kingma H. Selective vestibular ablation by intratympanic gentamicin in patients with unilateral active Ménière's disease: a prospective, double-blind, placebo-controlled, randomized clinical trial. Acta Otolaryngol (Stockh) 2004;124:172-5.
17. Cohen-Kerem R, Kisilevsky V, Einarson TR, Kozer E, Koren G, Rutka JA. Intratympanic gentamicin for Meniere's disease: a meta-analysis. Laryngoscope 2004 Dec;/114(12):2085-91.
18. Hone SW, Nedzelski JM. Selective chemical ablation as treatment for Ménière's disease. In: Harris JP, editor. Ménière's disease. The Hague: Kugler; 1999. p. 381-9.